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valve replacementKevin Bridge, MD, MSPH, and Robert Saeid Farivar, MD, PhD, Iowa City, IowaA 62-year-old woman presented with dyspnea on exertion,
and an echocardiogram demonstrated an ejection fraction of
55% to 60%, severe mitral regurgitation, and moderate aortic
regurgitation. The patient had rheumatic disease as a child, and
her valve failure was presumed to be due to rheumatic disease
sequelae. She previously had an axillary lymph node biopsy
for adenopathy at an outside hospital and was thought to
have Castleman’s disease. At the University of Iowa Heart
and Vascular Center, she underwent aortic and mitral valve
replacement through a full sternotomy and bicaval cannula-
tion. The aortic valve was replaced with a 21-mm Magna
ThermaFix Edwards bovine pericardial valve (Edward Life-
sciences, Irvine, Calif). The mitral valve was replaced with
a 29-mm St Jude Epic porcine valve (St Jude Medical Inc,
St Paul, Minn). Intraoperatively, the pericardium was found
to be inflamed and adherent to the aorta and right ventricle.
The native aortic valve was trileaflet, and both valves were
rubbery in consistency with significant nodules present. The
leaflets were friable. No calcification was found on the mitral
annulus. The mitral valve was not repairable.
The gross pathology showed tan white nodules, 0.3 cm in
the greatest dimensions, with spiculated appendages on the
surface of the valves. The microscopic pathology demon-
strated fibroelastic tissue with focal palisading and nonca-
seating granulomatous inflammation with central necrosis
(Figure 1). Postoperative recovery was uneventful. The
patient underwent multiple serologic tests that suggested
a diagnosis of Sjo¨gren’s syndrome (Table 1), which wasconfirmed with a positive Schirmer’s test and a labial sali-
vary gland biopsy.DISCUSSION
Sjo¨gren’s syndrome was first identified in 1933 by Dr
Henrik Sjo¨gren and is a chronic autoimmune disorder with
lymphocytic infiltration of the exocrine glands. Sjo¨gren’s
syndrome manifests with sicca symptoms, including xe-
rophthalmia and xerostomia. This disease primarily affects
women, and most cases are diagnosed during the middle-
age years. Sjo¨gren’s syndrome occurring without any other
manifestation of other autoimmune diseases has been la-
beled as primary Sjo¨gren’s syndrome. Secondary Sjo¨gren’sFIGURE 1. Mitral valve leaflet pathology demonstrating palisading and
granulomatous inflammation, 2003.
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TABLE 1. Serologic testing results
Test Result Normal range
C-reactive protein 4.6 (H) 0–20 mm/h
Erythrocyte sedimentation
rate
55 (H) <0.5 mg/dL
Rheumatoid factor 38 (H) <14 IU/mL
SSA antibody 127 (H) <19 units
SSB antibody 182 (H) <19 units
Anti-nuclear antibody titer >1:2560 (H) <1:40
Double-stranded DNA
antibody
423 (H) 0–200 IU/mL
Anti-RNP antibody 59 (H) 0–19 units
IgG, serum 2337 (H) 694–1618 mg/dL
ANCA screen Negative
Antistreptolysin O <55 0–330 IU/mL
Anti-cyclic citrullinated
peptide
4 0–19 units
C3 complement 151 90–180 mg/dL
C4 complement 18 16–47 mg/dL
Anti-Smith antibody 5 0–19 units
IgM, serum 89 60–263 mg/dL
IgA, serum 335 68–378 mg/dL
Angiotensin-1–converting
enzyme
16 8–52 U/L
RNP, Ribonucleoprotein; SSA, Sjo¨gren’s syndrome A; SSB, Sjo¨gren’s syndrome B;
ANCA, anti-neutrophil cytoplasmic antibody; Ig, immunoglobulin. High (H) is de-
noted in the result column, as is the normal reference range at the University of
Iowa Heart and Vascular Center.
Brief Clinical Reportssyndrome occurs when associated with another autoimmune
connective tissue disease, such as rheumatoid arthritis, sys-
temic lupus erythematosus, or scleroderma. Primary and
secondary Sjo¨gren’s syndromes occur with approximately
equal frequency.1 In addition to the salivary and lacrimal
glands, Sjo¨gren’s syndrome often affects other organ sys-
tems, including the gastrointestinal tract, skin, lungs, vascu-
lature, kidneys, bladder, and vagina.2
Mitral valve replacement for Sjogren’s syndrome has not
been previously reported. Previous studies have reported
echographic findings of valvular regurgitation and pericar-
dial effusion in patients with primary Sjo¨gren’s syndrome.3
There has been 1 previous case report of a patient with Sjo¨g-
ren’s syndrome associated with aortic valve regurgitation
who underwent aortic valve replacement for infective endo-
carditis.4 This is the first report of double-valve replacement
in connection with Sjo¨gren’s syndrome. A previous report
documented a patient with similar characteristics to our
patient, including age, gender, medical history, and clinical
symptoms on presentation. The patient was found to have
mitral and aortic valve stenosis. Further workup showede140 The Journal of Thoracic and Cardiovascular Surthe patient to be rheumatoid factor positive, antinuclear
antibody positive, and Sjo¨gren syndrome A positive. The
patient underwent a Schirmer’s test and a salivary gland
biopsy to confirm a diagnosis of Sjo¨gren’s syndrome. The
patient refused surgical treatment and was treated with
prednisolone therapy. Her symptoms reportedly improved,
although the valve lesions remained.5 To our knowledge,
there has been no previous documentation of cardiac valvu-
lar failure requiring double-valve replacement in connec-
tion with primary Sjo¨gren’s syndrome. In addition, this is
the initial report of insufficiency in Sjogren’s syndrome
being treated with valve replacement.
CONCLUSIONS
Pathology indicated a nonrheumatic autoimmune connec-
tive tissue disease for which the differential diagnosis
includes Sjo¨gren’s syndrome, systemic lupus erythemato-
sus, mixed connective tissue disorder, and undifferentiated
connective tissue disorder. This type of pathology is seen
in connection with rheumatoid arthritis, which is a form of
a connective tissue disorder, but the patient does not have
any clinical symptoms of rheumatoid arthritis. Laboratory
evidence supports a diagnosis of a connective tissue disor-
der. The patient was found to have high antinuclear
antibody, Sjo¨gren syndrome A and B, and anti-ribonucleo-
protein titers, suggesting a diagnosis of Sjo¨gren’s syndrome
or systemic lupus erythematosus. Sequelae of childhood
rheumatic fevers cause valvular dysfunction, but the typical
calcifications, valve thickening and fusion of the commis-
sures typically seen in conjunction with rheumatic fever,
were not observed. Sarcoidosis is a possible diagnosis based
on bihilar lymphadenopathy and the presence of noncaseat-
ing granulomas on the patient’s native valves, although sero-
logic tests did not support this diagnosis. Infectious causes
are other possible causes or valvular dysfunction, although
no infectious organisms were identified.
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